Please assess the completion status of the following clinical trial:

Trial Title: Study Evaluating Combination of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) in Premenstrual Dysphoric Disorder

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Generally healthy, women aged 18 to 49 years.~* History of severe PMS symptoms over the last year, as determined by the investigator.~* Regular 21 to 35 day menstrual cycle for 2 months prior to first study visit.~Exclusion Criteria:~* Major depressive disorder requiring antidepressant treatment or hospitalization within the last 3 years.~* Contraindication to combination oral contraceptives.~* Use of antidepressants/anxiolytics within 10 days of screening and for the duration of the study.~Other exclusions apply.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 49 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).